Skip to main content
NCBI home page
British Medical Journal logoLink to British Medical Journal
. 1970 Jan 3;1(5687):22–24. doi: 10.1136/bmj.1.5687.22

Treatment of Obese Non-Diabetic Patients with Phenformin. A Double-Blind Cross-Over Trial

A Hart, H Cohen
PMCID: PMC1700898  PMID: 4904162

Abstract

The effect of 50 mg. of sustained release phenformin capsules administered twice daily was compared with a placebo as an aid to weight reduction in obese non-diabetic patients. Phenformin and placebo were administered alternately in two three-month periods.

Weight loss on a 1,200-calorie diet was greater in the first three months than in the second three months regardless of treatment. There was no difference in weight loss between the phenformin and placebo groups in either the first or second three-month period. Serum cholesterol levels tended to fall in association with weight loss, but not apparently in relation to the size of the weight loss or to the treatment.

Full text

PDF
22

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boshell B. R., Roddam R. F., McAdams G. L. Effects of phenformin on insulin reserve and release. Ann N Y Acad Sci. 1968 Mar 26;148(3):756–767. doi: 10.1111/j.1749-6632.1968.tb27748.x. [DOI] [PubMed] [Google Scholar]
  2. Butterfield W. J. The effects of phenformin on peripheral glucose utilization and insulin action in obesity and diabetes mellitus. Ann N Y Acad Sci. 1968 Mar 26;148(3):724–733. doi: 10.1111/j.1749-6632.1968.tb27744.x. [DOI] [PubMed] [Google Scholar]
  3. Czyzyk A., Tawecki J., Sadowski J., Ponikowska I., Szczepanik Z. Effect of biguanides on intestinal absorption of glucose. Diabetes. 1968 Aug;17(8):492–498. doi: 10.2337/diab.17.8.492. [DOI] [PubMed] [Google Scholar]
  4. FAJANS S. S., MOORHOUSE J. A., DOORENBOS H., LOUIS L. H., CONN J. W. Metabolic effects of phenethylbiguanide in normal subjects and in diabetic patients. Diabetes. 1960 May-Jun;9:194–201. doi: 10.2337/diab.9.3.194. [DOI] [PubMed] [Google Scholar]
  5. Faludi G., Chayes Z., Gerber P. Rational treatment of the obese diabetic. Postgrad Med. 1968 Feb;43(2):92–96. doi: 10.1080/00325481.1968.11693142. [DOI] [PubMed] [Google Scholar]
  6. GRODSKY G. M., KARAM J. H., PAVLATOS F. C., FORSHAM P. H. Reduction by phenformin of excessive insulin levels after glucose loading in obese and diabetic subjects. Metabolism. 1963 Apr;12:278–286. [PubMed] [Google Scholar]
  7. Kreisberg R. A. Glucose metabolism in normal and obese subjects. Effect of phenformin. Diabetes. 1968 Aug;17(8):481–488. doi: 10.2337/diab.17.8.481. [DOI] [PubMed] [Google Scholar]
  8. Lyngsoe J., Trap-Jensen J. Phenformin-induced hypoglycaemia in normal subjects. Br Med J. 1969 Apr 26;2(5651):224–226. doi: 10.1136/bmj.2.5651.224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. PATEL D. P., STOWERS J. M. PHENFORMIN IN WEIGHT REDUCTION OF OBESE DIABETICS. Lancet. 1964 Aug 8;2(7354):282–284. doi: 10.1016/s0140-6736(64)93047-8. [DOI] [PubMed] [Google Scholar]
  10. Roginsky M. S., Barnett J. Double-blind study of phenethyldiguanide in weight control of obese nondiabetic subjects. Am J Clin Nutr. 1966 Oct;19(4):223–226. doi: 10.1093/ajcn/19.4.223. [DOI] [PubMed] [Google Scholar]
  11. Roginsky M. S., Sandler J. Phenformin in human obesity. Ann N Y Acad Sci. 1968 Mar 26;148(3):892–896. doi: 10.1111/j.1749-6632.1968.tb27763.x. [DOI] [PubMed] [Google Scholar]
  12. SADOW H. S. Mechanistic basis for the selection of hypoglycemic therapies. Appl Ther. 1962 Apr;4:369–377. [PubMed] [Google Scholar]
  13. Searle G. L., Cavalieri R. R. Glucose kinetics before and after phenformin in the human subject. Ann N Y Acad Sci. 1968 Mar 26;148(3):734–742. doi: 10.1111/j.1749-6632.1968.tb27745.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES